Enveric Biosciences
Yahoo Finance • 23 days ago
Enveric Biosciences receives second patent allowance for PTSD drug
CAMBRIDGE, Mass. - Enveric Biosciences (NASDAQ:ENVB) announced Wednesday it has received a second Notice of Allowance from the United States Patent and Trademark Office for compounds in its EVM401 Series, expanding its intellectual propert... Full story
Yahoo Finance • 2 months ago
Enveric's lead drug candidate shows additional receptor activity
CAMBRIDGE, Mass. - Enveric Biosciences (NASDAQ:ENVB), a biotechnology company currently trading at $1.25 per share and showing signs of being undervalued according to InvestingPro Fair Value metrics, announced Tuesday that its lead drug ca... Full story
Yahoo Finance • 2 years ago
Diamond Equity Research Initiates Coverage on Enveric Biosciences Inc. (NASDAQ: ENVB)
NEW YORK, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has initiated coverage of Enveric Biosciences Inc. (NASDAQ: ENVB). The in-depth 23-... Full story
Yahoo Finance • 2 years ago
10 Most Promising Psychedelic Stocks According To Analysts
In this article, we discuss 10 most promising psychedelic stocks according to analysts. If you want to see more stocks in this selection, check out 5 Most Promising Psychedelic Stocks According To Analysts. Psychedelic drugs encompass a r... Full story
